Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01966536
Other study ID # Neofol2013
Secondary ID
Status Withdrawn
Phase N/A
First received October 17, 2013
Last updated September 11, 2014
Start date November 2013
Est. completion date June 2015

Study information

Verified date September 2014
Source Hospital Universitario La Fe
Contact n/a
Is FDA regulated No
Health authority Spain: Ethics Committee
Study type Interventional

Clinical Trial Summary

Women delay maternity and, as a consequence, available oocyte number and their quality decrease (9-18% of all IVF patients). Different treatment protocols have been developped nevertheless none of them optimal: the number of oocytes retrieved depends on the present ones. New generation of oocytes and follicles has been defended by some authors and bone marrow seems to be involved. What seems crucial is the niche that produces paracrine signals able to activate dormant cells and to attract undifferentiated cells from other tissues (homing). This phenomenon has been described by our group in other human reproductive tissues like endometrium. The purpose of the study is to improve ovarian reserve in unfertile women with poor ovarian reserve by means of bone marrow protective capacity.

CD133+ cells obtained from bone marrow will be delivered into the ovarian artery allowing them to colonize ovarian niche.

The study hypothesis is that CD133+ cells will improve ovarian reserve differentiating themselves into germ cells or, more likely, stimulating the niche to activate dormant follicles.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date June 2015
Est. primary completion date March 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- < or= 40 years old

- FSH<15UI/L

- poor ovarian response after controlled ovarian stimulation with conventional doses (<3 oocytes) or two episodes of poor ovarian response after ovarian stimulation with maximal doses even if young or normal ovarian reserve study.

- Antral follicle count>2

- >1 antral follicle in the perfunded ovary

- AMH between 0,5 and 1pmol/L

- regular menstrual bleeding each 21-35 days

- To be candidate to autologous hematopoietic progenitors transplantation

Exclusion Criteria:

- Ovarian endometriosis

- Anovulation

- Any ovarian surgery considered risk factor of low ovarian response.

- Genetic factors associated to low ovarian response (Turner syndrome, FMR1 mutations...)

- Adquired conditions determining low response (chemotherapy, radiotherapy...)

- BMI > or = 30kg/m2

- Allergie to iodine

- Kidney failure

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
CD133+ cells transplantation into ovarian artery of one ovary


Locations

Country Name City State
Spain Hospital Universitario y Politécnico La Fe Valencia

Sponsors (1)

Lead Sponsor Collaborator
Hospital Universitario La Fe

Country where clinical trial is conducted

Spain, 

References & Publications (15)

Bhartiya D, Sriraman K, Parte S. Stem cell interaction with somatic niche may hold the key to fertility restoration in cancer patients. Obstet Gynecol Int. 2012;2012:921082. doi: 10.1155/2012/921082. Epub 2012 Apr 2. — View Citation

Eggan K, Jurga S, Gosden R, Min IM, Wagers AJ. Ovulated oocytes in adult mice derive from non-circulating germ cells. Nature. 2006 Jun 29;441(7097):1109-14. Epub 2006 Jun 14. — View Citation

Flesken-Nikitin A, Hwang CI, Cheng CY, Michurina TV, Enikolopov G, Nikitin AY. Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche. Nature. 2013 Mar 14;495(7440):241-5. doi: 10.1038/nature11979. Epub 2013 Mar 6. — View Citation

Garcia-Velasco JA, Isaza V, Requena A, Martínez-Salazar FJ, Landazábal A, Remohí J, Pellicer A, Simón C. High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial. Hum Reprod. 2000 Nov;15(11):2292-6. — View Citation

Gargett CE, Healy DL. Generating receptive endometrium in Asherman's syndrome. J Hum Reprod Sci. 2011 Jan;4(1):49-52. — View Citation

Hong H, Yen HY, Brockmeyer A, Liu Y, Chodankar R, Pike MC, Stanczyk FZ, Maxson R, Dubeau L. Changes in the mouse estrus cycle in response to BRCA1 inactivation suggest a potential link between risk factors for familial and sporadic ovarian cancer. Cancer Res. 2010 Jan 1;70(1):221-8. doi: 10.1158/0008-5472.CAN-09-3232. Epub 2009 Dec 22. — View Citation

Johnson J, Bagley J, Skaznik-Wikiel M, Lee HJ, Adams GB, Niikura Y, Tschudy KS, Tilly JC, Cortes ML, Forkert R, Spitzer T, Iacomini J, Scadden DT, Tilly JL. Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell. 2005 Jul 29;122(2):303-15. — View Citation

Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004 Mar 11;428(6979):145-50. Erratum in: Nature. 2004 Aug 26;430(7003):1062. — View Citation

La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010 Mar-Apr;16(2):113-30. doi: 10.1093/humupd/dmp036. Epub 2009 Sep 30. Review. — View Citation

Li J, Kawamura K, Cheng Y, Liu S, Klein C, Liu S, Duan EK, Hsueh AJ. Activation of dormant ovarian follicles to generate mature eggs. Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10280-4. doi: 10.1073/pnas.1001198107. Epub 2010 May 17. — View Citation

Munné S, Cohen J, Sable D. Preimplantation genetic diagnosis for advanced maternal age and other indications. Fertil Steril. 2002 Aug;78(2):234-6. — View Citation

Nagori CB, Panchal SY, Patel H. Endometrial regeneration using autologous adult stem cells followed by conception by in vitro fertilization in a patient of severe Asherman's syndrome. J Hum Reprod Sci. 2011 Jan;4(1):43-8. doi: 10.4103/0974-1208.82360. — View Citation

Taylor HS. Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA. 2004 Jul 7;292(1):81-5. — View Citation

White YA, Woods DC, Takai Y, Ishihara O, Seki H, Tilly JL. Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nat Med. 2012 Feb 26;18(3):413-21. doi: 10.1038/nm.2669. — View Citation

Zeng H, Li L, Chen JX. Overexpression of angiopoietin-1 increases CD133+/c-kit+ cells and reduces myocardial apoptosis in db/db mouse infarcted hearts. PLoS One. 2012;7(4):e35905. doi: 10.1371/journal.pone.0035905. Epub 2012 Apr 27. — View Citation

* Note: There are 15 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Ovarian reserve Measured by FSH-LH, oestradiol, AMH, antral follicle count 6 months Yes
Secondary Ovarian response to stimulation for oocyte retrieval Number of MII oocytes obtained 6 months Yes
See also
  Status Clinical Trial Phase
Recruiting NCT02896023 - Predictors of Ovarian Reserve in Infertile Women Phase 4
Recruiting NCT02240342 - Bone Marrow Transplantation to Promote Follicle Recruitment in Poor Ovarian Reserve N/A
Completed NCT01268930 - Comparison of Hemostatic Matrix and Bipolar Coagulation in Surgical Treatment of Endometriomas N/A
Completed NCT03492632 - Ovarian Reserve in Patients With Psoriasis
Withdrawn NCT02728245 - Trial Comparing Preoperative Dienogest Therapy Followed by Surgery vs. Upfront Surgery to Save Ovarian Reserve in Young Women With Ovarian Endometrioma Phase 2
Completed NCT05567731 - Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve N/A
Completed NCT03989921 - Ovarian Reserve and Embryo Implantation
Recruiting NCT02995343 - Evaluation of the Ovarian Reserve in Patients Who Hypogastric Arteries and or Uterine Arteries Had Been Ligated N/A
Recruiting NCT04151173 - Assessment of Ovarian Reserve After Laparoscopic Cystectomy Versus Aspiration/Electrocoagulation in the Treatment of Ovarian Endometrioma N/A
Enrolling by invitation NCT02377128 - Ovarian Reserve Following Bilateral Salpingectomy Versus Tubal Ligation During Cesarean Section N/A
Recruiting NCT03620838 - Endometrioma Per se Versus Treatment Related Reduction in Ovarian Reserve (ERROR-2 Trial)
Completed NCT02009228 - Single-port LC Might be Preferable for Managing Ovarian Dermoid Cyst. Phase 3
Completed NCT04762615 - Impact of Underlying Renal Disease and Immunosuppressive Regimen on Ovarian Reserve in Renal Patients
Recruiting NCT03009370 - The Effect of the Ovarian Reserve on the Recurrent Pregnancy Loss N/A
Completed NCT03621683 - Antioxidants vs. Ovarian Bio-stimulation Therapy to Rescue the Ovarian Reserve N/A
Completed NCT04058678 - Effects of Telomerase Reactivation With Danazol in Ovarian Function. N/A
Recruiting NCT05743218 - Clinical Efficacy of Acupuncture on the Liver Meridian in Women With Diminished Ovarian Reserve N/A
Recruiting NCT04487925 - Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders Phase 4
Terminated NCT01114464 - Impact of Chemotherapy on Ovarian Reserve in Young Women With Breast Cancer N/A
Active, not recruiting NCT00928044 - The Impact of Gynecological Surgery on Ovarian Function in Women of Reproductive Age: Postoperative Changes of Serum Anti-Müllerian Hormone (AMH) N/A